TN-BC is characterized by the lack of expression of the estrogen receptor (ER), progesterone receptor (PR) and epidermal growth factor receptor (HER2/ErbB2) and generally includes basal-like and claudin-low subtypes. This evidence concerns the gene ERBB2 and breast cancer.